✨
AI Summary
- Dr. Sonal Gupta explains CoRegen's engineered Treg approach for solid tumors.
- Targeting SRC3 aims to control multiple immune checkpoints simultaneously.
- Reimagining immunotherapy by focusing on regulatory T cells, not effector cells.
Guests on This Episode
SP
Sonal Gupta, MD, PhD
1 podcast appearance